The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday, June 8, 2017.
Microsoft Acquired Hexadite for $100M
The Deal:
Microsoft Corporation (NASDAQ: MSFT)
announced it has agreed to acquire Israeli cybersecurity company Hexadite. Terms of the agreement were not been disclosed, but the
purchase price is being reported as $100 million, according to TechCrunch.
Microsoft closed at $71.95, down $0.44.
Athenahealth Announces Agreement to Acquire Praxify Technologies for up to ~$63M in Cash
The Deal:
Athenahealth, Inc. (NASDAQ: ATHN)
announced it has entered into an agreement to acquire Praxify Technologies, Inc. for an aggregate purchase price of up to
approximately $63 million in cash. Praxify is focused on reinventing how doctors work with health data to drive productivity,
portability, and improved decision support.
Athenahealth closed at $141.02, up $1.94.
Smithfield Foods Parent WH Group Looking to Buy US, European Beef, Poultry Assets
The Rumor:
Smithfield Foods owner WH Group Ltd is seeking to acquire U.S. and European beef and poultry assets, according to a report from
Reuters. Smithfield CEO Ken Sullivan, in an interview, said he's potentially interested in diversifying into other meats to
broaden the company's product portfolio into meats other than pork, though no deals are pending.
WH Group's IR director Luis Chein said the company is looking for beef and poultry acquisitions in the United States and Europe,
but would not name specific assets.
Tyson shares spiked as high as $61.57 on the report. Pilgrim's Pride rose to $25.21 and Sanderson Farms hit a high of
$128.68.
Cabela's Acquisition Not Triggering FTC Concerns
The Rumor:
Shares Cabelas Inc (NYSE: CAB) spiked
higher as Capitol Forum reported that the FTC review of the acquisition of the company is not triggering major concerns. Cabela's
has agreed to be acquired by Bass Pro Shops for $61.50 per share in cash.
Cabela's shareholders will vote on the deal on July 11 and if approved is expected to close in Q3 of 2017.
Cabela's shares closed at $56.42, up $1.49.
SciClone Pharma to be Acquired by GL Capital for $11.18/Share Cash
The Deal:
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) is being acquired by a consortium consisting led by GL Capital Management for
$11.18 per share in cash. The transaction is valued at approximately $605 million and is expected to close this calendar year, is
subject to approval by SciClone stockholders.
SciClone Pharma closed at $10.90, up $0.80.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.